New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1
Go back to New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1| (NYSE: TAK) | Delayed: 15.47 -0.16 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.63 | 52 Week High | $0.55 | |||
| Open | $15.49 | 52 Week Low | $0.55 | |||
| Day High | $15.60 | P/E | N/A | |||
| Day Low | $15.39 | EPS | $-0.20 | |||
| Volume | 2,351,300 | |||||
